Forewarned is Forearmed! Unethical Drug Trials in the Developing Countries
Abstract
The journey of developing and marketing a new drug although profitable is a time consuming, expensive and laborious task. Clinical trials are mandatory for development of a new drug, device or method of treatment; without which safety and efficacy in humans, and optimal dosing cannot be established and overall adverse effects cannot be known.
Downloads
References
Goozner M. The $800 million pill: The truth behind the cost of new drugs. Berkley, California: University of California Press; 2004.
Monnet DL, MacKenzie FM, López-Lozano JM, Beyaert A, Camacho M, Wilson R, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432–41.
Vollmann J, Winau R. Informed consent in human experimentation before the Nuremberg code. BMJ (Clinical research ed.) 1996; 313:1445–9.
The Nuremberg Code (1947). BMJ 1996; 313:1448. 5 Fact Sheet on the 1946-1948, U.S. Public Health Service Sexually Transmitted Diseases (STD) Inoculation Study. U.S. Public Health Service Sexually Transmitted Diseases Inoculation Study of 1946-48. Available from:
http://www.hhs.gov/1946inoculationstudy/factsheet.html.
Flaherty M, Struck D. Life by Luck of the Draw. Washington Post. 2000 Dec 22.
Paliwal A. Drug Trials in India Killed 2031 persons. [Internet]. Available from: http://www.downtoearth.org. in/content/drug-trials-india-killed-2031-persons
Drugs firms must not prey on poverty. The Independent. 2011 Nov 14.
Lakhani, N. Drugs policy advisor under fire over links to pharmaceutical company. The Independent. 2011Nov 13.
Basu, I. India’s clinical trials and tribulations. Asia Times. 2004 Jul 23. [cited 2006 Apr 1]. Available from: http://www.atimes.com/atimes/South_Asia/FG23Df03.html.
Gulhati, CM. “Debate: Should clinical trials be allowed in India?” Business Standard, India. 2004 Feb 18.
Andrews J. U.S. Military sponsored vaccine trials and la resistance in Nepal. AJOB. 2005; 5:W1–3.
The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. 1979.
[cited 2005 March 15]. Available from: http://ohsr.od. nih.gov/ mpa/belmont.php3.
CFR - Code of Federal Regulations Title 21: Food and Drugs, Chapter I--Food and Drug Administration, Part 312 SUB PART B-Investigational new drug application. [Internet]. Available from: http://www.accessdata.fda.gov /scripts/cdrh/ cfdocs/cfcfr/cfrsearch.cfm?cfrpart=312.
CFR - Code of Federal Regulations Title 21: Food and Drugs, Chapter I--Food and Drug Administration, Part 312 Investigational new drug application. [Internet]. Available from: http://www.accessdata.fda.gov/ scripts/cdrh/ cfdocs/cfcfr/cfrsearch.cfm?cfrpart=312.
Levinson DR. Challenges to FDA’s ability to monitor and inspect foreign clinical trials (OEI-01-08-00510). Office of Inspector General, U.S. Department of Health and Human Services. June 2010. [cited 2011 Oct 10]. Available from: http://oig.hhs.gov/oei/reports/oei-01-
-00510.pdf.
Pondrom S. Clinical trials go global: as medical research expands to the global population will trial results sill apply to US populations?. The Rheumatologist. Nov 2011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Khalid Mahmood
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. 
